Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ONC
Stock Latest News
The Fly
BeOne Medicines price target lowered to $411 from $412 at Truist
18d ago
ONC
Premium
Ratings
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
1M ago
ONC
Premium
The Fly
BeOne Medicines initiated with an Outperform at Wolfe Research
1M ago
ONC
Premium
Company Announcements
BeOne Medicines Advances Combo Cancer Pill With Completed Phase 1 Bioavailability Study
1M ago
ONC
Premium
The Fly
BeOne Medicines treatment of hepatocellular carcinoma granted orphan designation
1M ago
ONC
Premium
Company Announcements
BeOne Medicines Advances BG-A3004 Into First-in-Human Skin Disease Trial: What Investors Should Watch
1M ago
ONC
Premium
Company Announcements
Early Cancer Drug Trial Termination Highlights Pipeline Risk for BeOne Medicines (ONC)
1M ago
ONC
Premium
The Fly
BeOne Medicines downgraded to Hold from Buy at Jefferies
1M ago
ONC
Premium
Company Announcements
BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors
1M ago
ONC
Premium
The Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
2M ago
ONC
JAZZ
Premium
The Fly
BeOne Medicines price target raised to $412 from $400 at Truist
2M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $425 from $417 at RBC Capital
2M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $410 from $400 at Guggenheim
2M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $405 from $394 at Barclays
2M ago
ONC
Premium
The Fly
BeOne Medicines reports Q4 adjusted EPS $1.95, consensus $1.30
2M ago
ONC
Premium
The Fly
BeOne Medicines sees 2026 revenue $6.2B-$6.4B, consensus $6.44B
2M ago
ONC
Premium
Pre-Earnings
Beigene, Ltd. (ONC) Q4 Earnings Cheat Sheet
2M ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $394 from $385 at Barclays
3M ago
ONC
Premium
Company Announcements
Zanubrutinib Update: What BeiGene’s BTK Intolerance Study Means for Oncology Investors
3M ago
ONC
Premium
Company Announcements
Prelude Therapeutics’ PRT2527 Trial Completion: What Investors Should Watch in Hematologic Oncology
3M ago
ONC
PRLD
Premium
Company Announcements
BeiGene’s BGB-24714 Solid Tumor Trial Terminated: What It Means for Oncology Investors
3M ago
ONC
Premium
Company Announcements
BeOne Medicines Targets CLL Leaders With New Phase 3 Head-to-Head Trial
3M ago
ONC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
